A four-site randomized clinical trial enrolled 280 first-degree relatives of individuals with Alzheimer disease ( mean age = 58 years , 71 % female ) ; each received lifetime Alzheimer disease risk information ( range : 13-74 % ) that incorporated apolipoprotein E genotype .
